Get the Stockscreener App
176.20
0.20%
-0.36
After Hours:
176.20
Irhythm Technologies Inc stock is traded at $176.20, with a volume of 216.74K.
It is down -0.20% in the last 24 hours and down -3.21% over the past month.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$176.56
Open:
$178.08
24h Volume:
216.74K
Relative Volume:
0.51
Market Cap:
$5.66B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-36.26
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
+0.34%
1M Performance:
-3.21%
6M Performance:
+78.36%
1Y Performance:
+207.08%
1-Day Range:
$176.01
$180.42
1-Week Range:
$174.37
$182.60
52-Week Range:
$55.92
$187.57
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
176.20 | 5.67B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
How iRhythm Technologies Inc. (I25) stock reacts to new regulationsWeekly Trend Summary & Stock Portfolio Risk Management - newser.com
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Robert W. Baird Analyst Says - MarketBeat
Baird Maintains iRhythm Technologies (IRTC) Outperform Recommendation - Nasdaq
Baird Raises Price Target for iRhythm Technologies (IRTC) to $22 - GuruFocus
What drives iRhythm Technologies Inc I25 stock priceCapital Gains Strategies & Unlock Smart Investment Tactics That Work - earlytimes.in
How resilient is iRhythm Technologies Inc. stock in market downturns2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
iRhythm Technologies $IRTC Shares Sold by Blair William & Co. IL - MarketBeat
We Think IRhythm Technologies (NASDAQ:IRTC) Has A Fair Chunk Of Debt - 富途牛牛
How to use Fibonacci retracement on iRhythm Technologies Inc.2025 Volatility Report & Daily Growth Stock Investment Tips - newser.com
Understanding iRhythm Technologies Inc.’s price movementChart Signals & Smart Money Movement Tracker - newser.com
Historical volatility pattern of iRhythm Technologies Inc. visualizedEarnings Beat & Risk Controlled Stock Alerts - newser.com
iRhythm Technologies' (IRTC) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Will iRhythm Technologies Inc. see short term momentumBear Alert & Accurate Buy Signal Notifications - newser.com
Is iRhythm Technologies Inc. stock a defensive play in 2025Weekly Trend Summary & High Return Trade Opportunity Guides - newser.com
Citigroup Maintains iRhythm Technologies (IRTC) Buy Recommendation - Nasdaq
Citigroup Raises Price Target for iRhythm Technologies (IRTC) to $205 | IRTC Stock News - GuruFocus
Evercore ISI Group Lowers Price Target for iRhythm Technologies (IRTC) | IRTC Stock News - GuruFocus
Evercore ISI Cuts iRhythm Technologies (NASDAQ:IRTC) Price Target to $175.00 - MarketBeat
Medical technology stock picks for a ‘cautious’ Q3: analysts - Proactive financial news
Multi asset correlation models including iRhythm Technologies Inc.Portfolio Value Report & Low Drawdown Investment Strategies - newser.com
Is iRhythm Technologies Inc. stock reversal real or fakeMarket Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Sentiment analysis tools applied to iRhythm Technologies Inc.2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Published on: 2025-10-06 02:07:09 - newser.com
What does recent volatility data suggest for iRhythm Technologies Inc.Portfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks - The Globe and Mail
Published on: 2025-10-05 01:42:03 - newser.com
Does Regulatory Scrutiny and Legal Action Challenge the Zio Platform Outlook for iRhythm Technologies (IRTC)? - Sahm
Why Analysts Are Rethinking the Growth Story for iRhythm Technologies After Recent Industry Shifts - Yahoo
How Regulatory and Legal Hurdles Will Impact iRhythm Technologies (IRTC) Investors - Yahoo Finance
iRhythm Technologies (IRTC): Valuation Check Following FDA Warning Letter and Compliance Lawsuit - Sahm
Exit strategy if you’re trapped in iRhythm Technologies Inc.July 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - newser.com
Custom strategy builders for tracking iRhythm Technologies Inc.2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com
Applying big data sentiment scoring on iRhythm Technologies Inc.Portfolio Update Report & Verified Momentum Stock Alerts - newser.com
2 Healthcare Stocks to Research Further and 1 Facing Challenges - Yahoo Finance
Intraday pattern recognizer results for iRhythm Technologies Inc.Market Volume Report & Expert Curated Trade Setups - newser.com
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know - Yahoo Finance
The Goldman Sachs Group Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - Defense World
Goldman Sachs Maintains iRhythm Technologies (IRTC) Neutral Recommendation - Nasdaq
Goldman Sachs Raises Price Target for IRTC, Maintains Neutral Ra - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Shares Down 6.8%What's Next? - MarketBeat
Regression analysis insights on iRhythm Technologies Inc. performanceGlobal Markets & Weekly Momentum Picks - newser.com
1 Cash-Producing Stock with Competitive Advantages and 2 We Question - The Globe and Mail
iRhythm Technologies, Inc. (IRTC) Shares Surge 96% Despite FDA Warning and Legal Challenges - MSN
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Irhythm Technologies Inc Stock (IRTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wilson Daniel G. | Chief Financial Officer |
Sep 02 '25 |
Sale |
167.28 |
737 |
123,285 |
39,470 |
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):